Abused Deterrent Formulations

This RSS feed URL is deprecated

- 0 Sekunde to go
...

Abuse-Deterrent Opioids Cross an Ethical Line

Cato Institute - 2 Tag alt
Among the steps the FDA is taking to combat this trend is its policy of encouraging drug makers to develop abuse-deterrent formulations of prescription opioids. The idea is to make it more difficult for opioid abusers to engage in nonmedical use of...

Statement from FDA Commissioner Scott Gottlieb, MD, on steps to promote development of generic versions of opioids ...
Statement from FDA Commissioner Scott Gottlieb, MD, on steps to promote development of generic versions of opioids ...

FDA.gov - 1 Woche alt
Until we're able to find new non-opioid forms of pain management for those who need treatment for pain, it's critical that we also continue to promote the development of opioids that are harder to manipulate and abuse, and take steps to encourage their...

FDA pushes for more abuse-deterrent opioid generics
FDA pushes for more abuse-deterrent opioid generics

BioPharma Dive - 1 Woche alt
"We know there can be a learning curve that comes with new technologies. Some prescribers may not be aware of the existence of these drugs, or may be uncertain of when to prescribe the abuse-deterrent versions. But we also know a significant barrier to...

Ensysce Biosciences Inc. to Present at Human Abuse Liability & Abuse-Deterrent Formulations Conference in ...

Business Wire (press release) - 4 Woche alt
SAN DIEGO--(BUSINESS WIRE)--Ensysce Biosciences Inc., an integrated drug delivery company for both small and large molecules, today announced that it will be participating at ExL's 4th annual Human Abuse Liability & Abuse-Deterrent Formulations ...und...

Opiate deaths demand serious action
Opiate deaths demand serious action

Nature.com - 2 Tag alt
The FDA's new guidelines urge drug manufacturers to make generic opioid painkillers that are more difficult to grind up and snort, among other measures. But, as the agency admits, it's not clear that such 'abuse-deterrent' formulations will prove...

Cato Institute Urges FDA, HHS To Stop Promotion Of Abuse-Deterrent Opioids

Inside Health Policy - 1 Tag alt
The Cato Institute is urging the government to stop promotion of abuse-deterrent formulations (ADFs) of opioids, saying they do more harm than good and promoting their use is unethical. One expert at the libertarian think tank maintains that FDA should...

The Insanity of Taxpayer-Funded Addiction
The Insanity of Taxpayer-Funded Addiction

New York Times - 3 Woche alt
In June, in response to a call for public comments, J. David Haddox, the company's vice president for policy, sent a letter to the commission outlining Purdue's proposed “policy options,” including recommending that the F.D.A. “convert” the opioid ...und...

US FDA guidance aims to encourage generic abuse-deterrent opioids

In-PharmaTechnologist.com - 1 Woche alt
“Opioids with abuse-deterrent formulations (ADFs) are intended to make certain types of abuse, such as crushing a tablet to snort or dissolving a capsule to inject, more difficult or less rewarding,”​ US Food and Drug Administration (FDA) commissioner...

State targets gaps in opioid-abuse treatment plans
State targets gaps in opioid-abuse treatment plans

Boston Herald - 2 Woche alt
The state also wants to make naloxone available over the counter, to boost access to methadone and other medication-assisted treatments, to approve rapid urine fentanyl tests, to use claims data for public policy research, and to fill abuse-deterrent ...und...

Pharmacy benefit managers are driving the opioid epidemic
Pharmacy benefit managers are driving the opioid epidemic

SW News Media - 2 Woche alt
Some have pointed to rising rates of unemployment and disability. Others have blamed an increase in opioid prescriptions. One overlooked culprit worsening the epidemic, however, comes straight from our health care system: pharmacy benefit managers, or...

News via Google. Noch mehr News zum Thema '"abuse deterrent formulations"'